The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Great day. Tiny market cap. Growing area of biotech. Bullish CEO. An announcement about solid revenues which dispel the offering fears will absolutely send this stock. Once profitable and valued as a multiple of EBITDA, £30-£50m market cap is very achievable
Such a small market cap. If they can start getting some good revenue and profits, this will go so much higher. Partly because it would remove the dilution risk but also because they will start to be valued based on multiples of EBITDA. Not hard to then get up to £30-50m market cap
Not following too much these days as got wiped out after the raise and haven’t bought anymore. Just going to let it run and see what comes out of the final drill. Had a lot of hope for this stock and thought we would have a few shots but they only managed three quarters of a shot…which wasn’t quite what I had bought in for.
A commercial discovery and a recovery to around the 2p level would be delightful